ENTITY
nirmatrelvir/ritonavir
nirmatrelvir/ritonavir
PulseAugur coverage of nirmatrelvir/ritonavir — every cluster mentioning nirmatrelvir/ritonavir across labs, papers, and developer communities, ranked by signal.
Total · 30d
2
2 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
0
0 over 90d
TIER MIX · 90D
TOPICS
RELATIONSHIPS
RECENT · PAGE 1/1 · 2 TOTAL
-
Pfizer CEO bets $23B on oncology, leveraging AI for cancer breakthroughs
Pfizer CEO Albert Bourla is spearheading a significant strategic shift for the company, reallocating $23 billion from its COVID-19 windfalls towards oncology research and development. This pivot aims to secure Pfizer's …
-
Pfizer CEO admits using 'emotional blackmail' to drive COVID-19 vaccine production
Pfizer CEO Albert Bourla has revealed his use of intense motivational tactics, which he described as "emotional blackmail," to drive his teams to achieve unprecedented goals during the COVID-19 pandemic. Bourla employed…